Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Apr 7, 2005; 11(13): 2041-2044
Published online Apr 7, 2005. doi: 10.3748/wjg.v11.i13.2041
Published online Apr 7, 2005. doi: 10.3748/wjg.v11.i13.2041
Table 1 Hormonal secretion before starting SR-LAN (0) and at 3, 6, 12 and 18 mo of therapy.
| 0 Before starting SR-LAN | 3 mo | 6 mo | 12 mo | 18 mo | |
| CgA (ng/mL) | 900.0 | 108.0 | 119.0 | 45.5 | 34.7 |
| NSE (ng/mL) | 6.9 | 5.0 | 5.8 | 6.9 | 6.3 |
| Serotonin (ng/mL) | 412 | 248 | 98 | 67 | 80 |
| 5-HIAA (mg/24 h) | 14.0 | 2.5 | 2.4 | 3.2 | 2.2 |
- Citation: Bondanelli M, Ambrosio MR, Zatelli MC, Cavazzini L, Al Jandali Rifa’y L, degli Uberti EC. Regression of liver metastases of occult carcinoid tumor with slow release Lanreotide therapy. World J Gastroenterol 2005; 11(13): 2041-2044
- URL: https://www.wjgnet.com/1007-9327/full/v11/i13/2041.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i13.2041